In this article on PharmExec.com, Nekzad Shroff
and Karim Damji
discuss the necessary steps for the pharma industry to adopt modernized technologies and strategies.
Karim states in the article, “Pharma companies have been doing it the hard way for a very long time. The tools and technologies that are available to other industries have not been widely adopted by pharma, simply because of a fear of taking that legal risk associated with doing something novel,”
Nekzad asserts, “The adoption of RWE by pharma leaders is a different problem from developing the actual capabilities involved. Adoption requires a shift to an exploratory mindset. There needs to be a tolerance of ambiguity and imperfect data to be able to actually interpret and gain insights in spite of data gaps.”